Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 and HER-2 alterations in renal cell carcinoma.

Urology - 1 Oct 1997

Zhang X H, Takenaka I, Sato C, Sakamoto H

Abstract excerpt

OBJECTIVES: To investigate protein expression and genetic aberrations of p53 and HER-2 in renal cell carcinoma (RCC) as well as possible association of p53 and HER-2 abnormalities with the tumor behavior of RCC. METHODS: Formalin-fixed and paraffin-embedded tissue blocks from 70 patients with RCC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-2

Share to Genes, p53

Share to Kidney Neoplasms

Share to Mutation

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9338750
DOI: 10.1016/S0090-4295(97)00258-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-9338750-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 and HER-2 alterations in renal cell carcinoma.PMID 9338750Read ↗

p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?Semantic proximity Read ↗

P53 mutations and other prognostic factors of renal cell carcinoma.Semantic proximity Read ↗

Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma.Semantic proximity Read ↗

p53 mutations and MDM-2 amplification in renal cell cancers.Semantic proximity Read ↗

Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.Semantic proximity Read ↗

Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.Semantic proximity Read ↗

Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2.Semantic proximity Read ↗

Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma.Semantic proximity Read ↗

Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.Semantic proximity Read ↗

Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.Semantic proximity Read ↗

Concomitant overexpression of theEGFR anderbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasisSemantic proximity Read ↗

HER-2/neu and p53 in Osteosarcoma: An Immunohistochemical and Fluorescence In Situ Hybridization AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.